ValeVALE
VALE
About: Vale is a large global miner and the world's largest producer of iron ore and pellets. In recent years the company has sold noncore assets such as its fertilizer, coal, and steel operations to concentrate on iron ore, nickel, and copper. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets. The base metals division is much smaller, consisting of nickel mines and smelters along with copper mines producing copper in concentrate. In 2024, Vale sold a minority 10% stake in energy transition metals, its base metals business, likely the first step in separating base metals and iron ore.
Employees: 64,610
0
Funds holding %
of 7,425 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
2% more repeat investments, than reductions
Existing positions increased: 165 | Existing positions reduced: 161
0.14% less ownership
Funds ownership: 13.58% [Q3] → 13.44% (-0.14%) [Q4]
1% less first-time investments, than exits
New positions opened: 88 | Existing positions closed: 89
3% less call options, than puts
Call options by funds: $597M | Put options by funds: $618M
3% less funds holding
Funds holding: 505 [Q3] → 492 (-13) [Q4]
6% less funds holding in top 10
Funds holding in top 10: 17 [Q3] → 16 (-1) [Q4]
24% less capital invested
Capital invested by funds: $7.15B [Q3] → $5.42B (-$1.73B) [Q4]
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$9
8%
downside
Avg. target
$10.70
9%
upside
High target
$11.50
17%
upside
4 analyst ratings
2 positive
50%
2 neutral
50%
0 negative
0%
CICC | 15%upside $11.30 | Outperform Initiated | 12 May 2025 |
UBS Myles Allsop 67% 1-year accuracy 2 / 3 met price target | 8%downside $9 | Neutral Maintained | 28 Apr 2025 |
RBC Capital Marina Calero 100% 1-year accuracy 1 / 1 met price target | 12%upside $11 | Sector Perform Downgraded | 17 Apr 2025 |
B of A Securities Caio Ribeiro 33% 1-year accuracy 1 / 3 met price target | 17%upside $11.50 | Buy Upgraded | 10 Apr 2025 |
Financial journalist opinion
Based on 13 articles about VALE published over the past 30 days
Neutral
Business Wire
28 minutes ago
AviadoBio Announces ASPIRE-FTD Phase 1/2 Clinical Trial in the UK at Cambridge University Hospitals NHS Foundation Trust, Cardiff and Vale University Health Board, and University College London
LONDON--(BUSINESS WIRE)--AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced that its Phase 1/2 ASPIRE-FTD clinical trial is now open in the UK. The trial is evaluating AVB-101, an investigational gene therapy, in people with frontotemporal dementia (FTD) with GRN gene mutations (FTD-GRN). Cambridge University Hospitals NHS Foundation Trust (CUH), which hosts an internationally.
Positive
Seeking Alpha
1 week ago
Build A 12%+ Yield On Cost By 2035 With May's Top 10 High-Yield Picks
In this article, I present 10 attractive high-yield investment options for this month of May 2025, which not only offer dividend income but also potential for dividend growth. The selection process involves analyzing financial ratios, competitive advantages, valuations, and diversification across industries and countries to minimize risks and maximize returns. Highlighted top picks for May 2025 include VICI Properties, Chevron, Canadian Natural Resources, Pfizer, Altria, CVS Health, Toronto-Dominion Bank, Comcast, Vale, and Ares Capital.
Positive
Zacks Investment Research
2 weeks ago
Investors Heavily Search VALE S.A. (VALE): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to VALE (VALE). This makes it worthwhile to examine what the stock has in store.
Negative
Zacks Investment Research
2 weeks ago
Vale Q1 Revenues & Earnings Miss Estimates on Lower Iron Ore Prices
VALE witnesses a year-over-year decline in both its top and bottom lines in the first quarter of 2025 due to lower iron ore prices.
Negative
Seeking Alpha
2 weeks ago
Vale Q1: Still Undervalued? Let's Revisit The Thesis After A Challenging Quarter
Vale's net revenue decreased by 4% YoY and 20% QoQ to $8.1 billion due to lower price realization in the ferrous division and seasonal rain effects. Despite this downturn, I foresee improvement as the resolution of the tariff impasse may prompt China to boost infrastructure and civil construction investments. The weak revenue performance is primarily attributed to external factors, suggesting potential for recovery with favorable market conditions.
Negative
Seeking Alpha
2 weeks ago
Rio Tinto Vs. Vale: Inventory Doesn't Lie
Since my last analysis, new tariffs announced by President Trump have added additional – and large – uncertainties to mining stocks. I expect high tariffs to disrupt global trade flows, decrease demand for basic metals, and increase operational costs for both RIO and VALE. As a reflection of these macroscopic pressures, the latest data show that both companies are experiencing elevated inventory.
Neutral
Zacks Investment Research
2 weeks ago
Compared to Estimates, VALE (VALE) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for VALE (VALE) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Neutral
Seeking Alpha
2 weeks ago
Vale S.A. (VALE) Q1 2025 Earnings Call Transcript
Vale S.A. (NYSE:VALE ) Q1 2025 Earnings Conference Call April 25, 2025 10:00 AM ET Company Participants Gustavo Pimenta - President Marcelo Bacci - Executive Vice President, Finance and Investor Relations Rogerio Nogueira - Executive Vice President Commercial and Development Carlos Medeiros - Executive Vice President, Operations Shaun Usmar - Chief Executive Officer of Vale Base Metals Conference Call Participants Rafael Barcellos - Bradesco BBI Caio Greiner - UBS Caio Ribeiro - Bank of America Daniel Sasson - Itau BBA Carlos Alba - Morgan Stanley Rodolfo Angele - JP Morgan Marina Calero - RBC Christopher Lafemina - Jefferies Yuri Pereira - Santander Operator Good morning, ladies and gentlemen. Welcome to Vale's First Quarter 2025 Earnings Call.
Negative
Proactive Investors
2 weeks ago
Vale shares fall as Q1 profit hit by weaker metals demand
Shares of Brazilian mining giant Vale SA (ADR) (NYSE:VALE) fell 2% on Friday morning after the company reported a 17% drop in first-quarter net profit, missing analyst expectations as lower iron ore prices and subdued global demand weighed on results. Vale posted a net profit of $1.39 billion for the three months ended March 31, down from $1.67 billion a year earlier and below the $1.68 billion expected by analysts polled by LSEG.
Positive
Seeking Alpha
3 weeks ago
Vale Q1 Earnings Preview: A Bumpy Road But Still A Buy At These Valuations
Vale S.A. remains a strong buy due to its operational advantage as a low-cost iron ore producer, despite current market headwinds and high interest rates in Brazil. The company's robust dividend strategy and potential for high free cash flow yield highlight its long-term investment appeal, even amid short-term challenges. Trump's tariffs and China's economic slowdown have negatively impacted Vale's performance, but the pessimism is already priced into the stock, presenting a buying opportunity ahead of 1Q25.
Charts implemented using Lightweight Charts™